Just diagnosed with Combined oxidative phosphorylation deficiency?
You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Combined oxidative phosphorylation deficiency, look for clinical trials, and connect with others living with it — all in one place.
Open the full interactive Combined oxidative phosphorylation deficiency hub →Overview
Combined oxidative phosphorylation deficiency is a rare condition. Also known as COXPD12, Combined oxidative phosphorylation defect type 12, LTBL. Tomeko brings together the specialists, research, clinical trials, treatments and community for Combined oxidative phosphorylation deficiency so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:314051 · OMIM 614924 · ICD-10 E88.8 · GARD 0012893
Find care for Combined oxidative phosphorylation deficiency
Authoritative references for Combined oxidative phosphorylation deficiency
Research & market landscape for Combined oxidative phosphorylation deficiency
Following Combined oxidative phosphorylation deficiency for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for Combined oxidative phosphorylation deficiency — the real-world landscape behind the condition, in one place.
- Latest Combined oxidative phosphorylation deficiency research on PubMed ↗
- Recruiting Combined oxidative phosphorylation deficiency trials on ClinicalTrials.gov ↗
- Explore the Combined oxidative phosphorylation deficiency research & specialist footprint on Tomeko
Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for Combined oxidative phosphorylation deficiency and every rare condition. See how Tomeko works with industry →
Common questions
What is Combined oxidative phosphorylation deficiency?
Combined oxidative phosphorylation deficiency is a rare condition. Also known as COXPD12, Combined oxidative phosphorylation defect type 12, LTBL. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for Combined oxidative phosphorylation deficiency together in one place.
What are the symptoms of Combined oxidative phosphorylation deficiency?
Symptoms of Combined oxidative phosphorylation deficiency vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats Combined oxidative phosphorylation deficiency.
How is Combined oxidative phosphorylation deficiency treated?
Treatment for Combined oxidative phosphorylation deficiency depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see Combined oxidative phosphorylation deficiency, and review current options with them.
What causes Combined oxidative phosphorylation deficiency — is it genetic?
The cause and inheritance of Combined oxidative phosphorylation deficiency are described in the authoritative references linked on this page. A genetics or specialist clinician who treats Combined oxidative phosphorylation deficiency can explain what it means for you and your family.
I was just diagnosed with Combined oxidative phosphorylation deficiency — what should I do first?
Start by learning the basics from an authoritative source, find a specialist or center that sees Combined oxidative phosphorylation deficiency, and connect with a patient organization. Tomeko brings these together on one hub.
Where can I find a specialist for Combined oxidative phosphorylation deficiency?
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Combined oxidative phosphorylation deficiency, filtered to your area.
Are there clinical trials for Combined oxidative phosphorylation deficiency?
Tomeko shows live, recruiting studies for Combined oxidative phosphorylation deficiency from ClinicalTrials.gov on the hub.
Related conditions
Other conditions on Tomeko you may be looking for:
- 2-aminoadipic 2-oxoadipic aciduria
- 3 beta-Hydroxysteroid dehydrogenase deficiency
- 3-hydroxy-3-methylglutaryl-CoA synthase deficiency
- 3-Hydroxyisobutyric aciduria
- 3-hydroxyisobutyryl-CoA hydrolase deficiency
- 3-methylglutaconic aciduria type 1
- 3-Methylglutaconic aciduria type 2
- 3-Methylglutaconic aciduria type 3